Biomea Fusion is trading at $1.75 (-5.15%) on September 10, 2026, amid broad market weakness following hotter-than-expected August producer-price inflation.

  • The S&P 500, Nasdaq Composite, and Dow Jones are each down more than 0.5%, while higher Treasury yields are pressuring rate-sensitive equities.
  • No clear company-specific negative announcement was identified.
  • Biomea Fusion is scheduled for one-on-one investor meetings at Citi’s 2026 Biopharma Back to School Conference on September 10.